PC: Dialysis Inc
Plan B, the most well-known morning-after pill in the country, is becoming more popular among women since the Supreme Court in June overruled Roe v. Wade, the legal decision that granted Americans the right to an abortion.
Plan B is not always available even if it is sold over the counter. Many people with modest incomes find it to be too pricey at an average cost of $40–$50. Pharmacies are permitted to refuse to dispense it in some states, and shops frequently store the substance out of consumers’ reach.
The Food and Drug Administration’s labelling warns that the product may “prevent a fertilised egg from attaching to the womb,” a claim that scientists and medical professionals say is not supported by scientific evidence but was included on the label in order to get Plan B’s over-the-counter status approved. Now, even more restrictions may be coming for Plan B. Medical experts disagree with the anti-abortion campaigners who claim that any intervention with an egg constitutes an abortion.
Justice Clarence Thomas proposed that the Supreme Court reconsider its earlier opinion on contraceptives in the wake of the court’s decision. For the brand and its customers, unclear label language might spell trouble.